TRENDS IN MICROBIOLOGY is a premier academic journal published by CELL PRESS, renowned for its high-impact research contributions in the fields of microbiology, infectious diseases, medical microbiology, and virology. With an impressive impact factor and a notable Scopus ranking—placing it in the top tiers of its categories, including a remarkable Q1 status in multiple disciplines—this journal is essential for researchers, professionals, and students aiming to stay at the forefront of innovative microbial research and ongoing advancements in pathogen biology. Since its inception in 1993, TRENDS IN MICROBIOLOGY has provided a platform for thought-provoking reviews and critical insights, fostering discussions that shape the future of the microbiological sciences. Based in the United Kingdom, TRENDS IN MICROBIOLOGY continues to lead the way in disseminating vital knowledge within the global scientific community.

MICROBIOLOGY AND IMMUNOLOGY, an esteemed journal published by WILEY, serves as a vital resource for researchers and professionals in the fields of microbiology, immunology, and virology. With its ISSN 0385-5600 and E-ISSN 1348-0421, this journal has been a cornerstone in scientific literature since its inception in 1977, bridging decades of research and innovation through its comprehensive coverage of emerging trends and discoveries. Although this journal operates without open access, it maintains a commendable presence in academic circles, reflected in its 2023 Quartile rankings of Q3 across the categories of Immunology, Microbiology, and Virology. As part of an important discourse in these disciplines, MICROBIOLOGY AND IMMUNOLOGY ensures its scholarly contributions are relevant to both seasoned researchers and emerging scholars. Positioned in a competitive journal landscape, with Scopus ranks indicating a median percentile across its fields, it remains committed to advancing knowledge through peer-reviewed articles, thereby supporting the continuous evolution of its focus areas. The journal's current scope encompasses topics critical for understanding pathogen-host interactions and the immune response, making it a crucial publication for any academic library or individual scholar dedicated to the biological sciences.

APMIS is a distinguished academic journal published by WILEY that serves as a vital resource for researchers and practitioners in the fields of Immunology, Allergy, Microbiology, and Pathology. Established in 1988 and continuing its mission through 2024, this journal facilitates the dissemination of high-quality research findings, contributing to the intersection of multiple disciplines within the medical sciences. With an ISSN of 0903-4641 and an E-ISSN of 1600-0463, APMIS is categorized in 2023's Q2 and Q3 quartiles across various domains, reflecting its significant impact, with rankings such as #50/208 in Pathology and Forensic Medicine and #121/233 in Immunology and Allergy. Although it currently does not offer open access options, the journal’s rigorous peer-review process ensures that published articles maintain the highest standards of scholarship. With its focus on innovative research, APMIS continues to occupy a pivotal role for those seeking to advance their expertise and contribute to scientific dialogue in these essential fields.

Microorganisms is a leading open-access journal published by MDPI based in Switzerland, catering specifically to the rapidly evolving fields of microbiology and virology. Since its inception in 2013, the journal aims to foster the dissemination of high-quality research through its comprehensive and interdisciplinary platform, with a particular focus on both fundamental and applied microbiological sciences. Contributing to its esteemed reputation, Microorganisms holds a commendable Q2 ranking in the categories of Microbiology and Virology, as well as in Medical Microbiology, highlighting its significance in the academic community. With a consistent impact, evidenced by its rankings in Scopus—such as rank #25 in Virology and #56 in Microbiology—the journal serves as an invaluable resource for researchers, professionals, and students looking to stay at the forefront of microbiological research. As an open-access journal, Microorganisms ensures that vital research findings are readily available to a global audience, promoting collaboration and innovation in the study of microbial life and its implications for health and disease.

Comparative Immunology Microbiology and Infectious Diseases, published by Elsevier Science Ltd, is a prominent journal dedicated to advancing the fields of immunology, microbiology, infectious diseases, and veterinary sciences. Established in 1978, this journal has become a vital resource for researchers and professionals alike, with a commendable impact factor that reflects its significance in academia. The journal, available in both print and electronic formats (ISSN: 0147-9571, E-ISSN: 1878-1667), stands out for its commitment to disseminating innovative research findings, particularly through its categorization in Q2 and Q3 quartiles across various related disciplines as of 2023. The journal aims to provide insightful comparative analyses that enhance our understanding of host-pathogen interactions, immune responses, and disease manifestations. With a global readership base, it serves as a platform for collaborative discourse among scientists and professionals, ultimately contributing to the improvement of health outcomes worldwide.

Frontiers in Cellular and Infection Microbiology, published by FRONTIERS MEDIA SA, is a leading Open Access journal that has been at the forefront of microbiological research since 2011. Located in Switzerland, this journal aims to provide a platform for innovative and impactful studies in various domains including immunology, infectious diseases, and medical microbiology. With an impressive range of quartile rankings—Q1 in Infectious Diseases, Microbiology, and Microbiology (medical), and Q2 in Immunology—as of 2023, it positions itself as a highly reputable source in the academic community. Furthermore, its Scopus rankings highlight its significance within the respective fields, with top percentiles in key categories, making it an essential resource for researchers, professionals, and students alike. As an Open Access publication, it ensures that vital findings are accessible to a global audience, fostering collaboration and advancement in science.

MOLECULAR MICROBIOLOGY is a prestigious academic journal published by Wiley that has been at the forefront of research in the fields of microbiology and molecular biology since its inception in 1987. With an impressive Q1 rating in Microbiology and a Q2 rating in Molecular Biology for 2023, this journal serves as a vital platform for disseminating high-impact research that advances our understanding of microbial processes and interactions at the molecular level. The journal's ISSN is 0950-382X, and the E-ISSN is 1365-2958, making it easily accessible to a global audience of researchers, professionals, and students. Though not an Open Access journal, MOLECULAR MICROBIOLOGY remains committed to providing valuable insights and fostering knowledge exchange in the academic community. Situated in the United Kingdom and indexed in prominent databases like Scopus, the journal holds a strong standing, with current rankings reflecting its influential role in the academic landscape. Researchers in the field are invited to contribute and engage with cutting-edge discoveries that will shape the future of microbiological sciences.

INFECTION AND IMMUNITY is a distinguished peer-reviewed journal published by the American Society for Microbiology, focusing on groundbreaking research in the fields of infection, immunology, microbiology, and parasitology. Established in 1971, this journal has built a robust legacy, converging years of scientific discovery with a vision towards 2024 and beyond. With an impressive Impact Factor, the journal holds significant rankings in various categories; its Q1 status in both Infectious Diseases and Parasitology underscores its high relevance and quality within the scientific community. Researchers and professionals alike will benefit from its content, as it promotes the latest advances in understanding immune responses and infectious agents, further legitimizing its place among the top quartiles of its respective fields. Access options are provided through traditional subscription models, ensuring a broad charitable dissemination of knowledge. As a pivotal resource for scholars and practitioners alike, INFECTION AND IMMUNITY stands at the forefront of microbiological and immunological research, fostering essential discourse that is crucial for advancing public health and scientific insight.

The ISME Journal, published by Oxford University Press, stands as a premier multidisciplinary platform dedicated to advancing the fields of Ecology, Evolution, Behavior, and Systematics as well as Microbiology. With its ISSN of 1751-7362 and E-ISSN 1751-7370, this renowned journal has successfully maintained a prestigious reputation reflected in its commendable Q1 rankings across both fields in 2023. It ranks #7 out of 721 in Ecology, Evolution, Behavior, and Systematics and #8 out of 182 in Microbiology, placing it in the top percentiles of relevant Scopus categories. Covering original research, reviews, and methodologies, the journal aims to foster interdisciplinary collaboration and inspire new paradigms in microbiome research, environmental processes, and evolutionary dynamics. Researchers, professionals, and students are encouraged to submit their findings to a journal that not only reaches a global audience but also influences the direction of ongoing scientific discourse. With a commitment to excellence, the ISME Journal represents an essential resource for anyone engaged in these transformative fields of study.

Genes & Diseases, published by KEAI PUBLISHING LTD, is a premier open-access journal dedicated to advancing the fields of genetics, biochemistry, and molecular biology. Established in 2014 and headquartered in Beijing, China, this journal has quickly risen to prominence, securing a place in the prestigious Q1 quartile in Biochemistry and Genetics (clinical), as well as Q2 in Cell Biology and Q1 in Molecular Biology as of 2023. With a commitment to disseminating cutting-edge research, Genes & Diseases serves as a critical platform for researchers, professionals, and students alike, ensuring that high-quality scientific work is openly accessible to the global community. The journal's exceptional impact is underscored by its selective Scopus rankings, which reflect its influence and relevance in key scientific domains, making it an essential resource for those exploring the intersections of genetics and disease pathology.